TREATMENT GUIDELINES

New guidelines: Don’t treat most sinus infections with antibiotics

The majority (90% to 98%) of sinus infections are caused by viruses and should not be treated with antibiotics, according to new guidelines from the Infectious Diseases Society of America. » More

Editor's Pick

Racial/ethnic disparities exist in the diagnosis, treatment of depression

Minorities are less likely to receive a depression diagnosis and be treated for it than non-Hispanic Whites, according to a new study published online and ahead-of-print on December 15, 2011, in the American Journal of Public Health. » Click here.

CONTINUING EDUCATION

The latest FDA drug approvals: What you need to know

Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

CLINICAL NEWS

Rivaroxaban as effective as standard therapy for treating PE, with lower risk of bleeding

Rivaroxaban, an oral blood thinner, is equally effective as standard therapy for the treatment of pulmonary embolism and may cause fewer bleeding complications, according to new data. » More

Blood-pressure drug might curb PTSD-related nightmares

The blood-pressure medication prazosin was found to be an effective treatment to curb nightmares related to post-traumatic stress disorder, according to a poster presentation at the 20th European Congress of Psychiatry in Prague. » More

Rituximab may be better second-line RA therapy when anti-TNF fails

Switching patients with rheumatoid arthritis to rituximab (Rituxan, Genentech) may be more effective than switching them to a second alternative anti-tumor necrosis factor (anti-TNF) after a first anti-TNF therapy has failed, according to a study published online in Arthritis Care & Research. » More

Risk of secondary cases of C. difficile in households doesn’t justify interventions

The risk of Clostridium difficile infection among households is too low to justify interventions, other than avoiding unnecessary antimicrobials, according to a new study published in April’s Journal of Infection. » More

Survey

Which of the following healthcare industry trends do you believe will have the most significant impact on the ability to manage pharmacy expenditures over the next 3-5 years?

a) Aging US population
b) Expanded coverage via HC reform
c) Price inflation by drug manufacturers
d) Growth in the specialty drug market
e) Increased incidence of key chronic diseases (eg, diabetes, CAD, asthma/COPD, etc.)

Click here and see what your colleagues think, too.

Want to see the results of our last survey regarding Medicare's coverage policy of immunosuppressive therapy following kidney transplantation? Click here.

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff

Resources

Digital Edition